Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tenax Therapeutics (TENX)

Tenax Therapeutics (TENX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,322
  • Shares Outstanding, K 9,219
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,390 K
  • 60-Month Beta 2.22
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.43
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.99
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/12/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +21.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8600 +4.97%
on 06/30/20
1.6000 -43.58%
on 06/08/20
-0.7373 (-44.96%)
since 06/02/20
3-Month
0.5101 +76.97%
on 04/13/20
2.6800 -66.32%
on 06/02/20
+0.3577 (+65.63%)
since 04/02/20
52-Week
0.2500 +261.08%
on 03/12/20
2.6800 -66.32%
on 06/02/20
-0.4473 (-33.13%)
since 07/02/19

Most Recent Stories

More News
Company News for June 3, 2020

Companies in the news are: DCI, TENX, TRVN, BHTG

DCI : 46.23 (+1.92%)
TRVN : 1.5300 (-3.16%)
TENX : 0.9027 (+0.30%)
BHTG : 1.9000 (-7.32%)
Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high...

TENX : 0.9027 (+0.30%)
Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TENX, ALNA, TRVN, ADAP, and ACB.

ACB : 12.27 (unch)
ACB.TO : 16.45 (-0.48%)
TENX : 0.9027 (+0.30%)
Tenax Therapeutics Reports Positive Results from Phase 2 Trial of Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

--- Demonstrated a significant improvement with 6-minute walk distance

TENX : 0.9027 (+0.30%)
Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 "HELP Study" of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high...

TENX : 0.9027 (+0.30%)
Tenax Therapeutics Completes Enrollment in Phase 2 Pulmonary Hypertension Trial

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high...

TENX : 0.9027 (+0.30%)
Tenax Therapeutics Announces $2.75 Million Registered Direct Offering Priced At-the-Market

Tenax Therapeutics, Inc. (Nasdaq: TENX) ("Tenax" or the "Company"), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary...

TENX : 0.9027 (+0.30%)
Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high...

TENX : 0.9027 (+0.30%)
Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high...

TENX : 0.9027 (+0.30%)
Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high...

TENX : 0.9027 (+0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade TENX with:

Business Summary

Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. The Company specializes in creating pharmaceuticals and medical devices in the fields of oxygen therapeutics, blood substitutes, and liquid ventilation...

See More

Key Turning Points

2nd Resistance Point 1.0062
1st Resistance Point 0.9545
Last Price 0.9027
1st Support Level 0.8765
2nd Support Level 0.8502

See More

52-Week High 2.6800
Fibonacci 61.8% 1.7517
Fibonacci 50% 1.4650
Fibonacci 38.2% 1.1783
Last Price 0.9027
52-Week Low 0.2500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar